ContraVir Pharmaceuticals (CTRV) Short Interest Ratio & Short Volume

Short interest is the volume of ContraVir Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 52,400 shares of CTRV short. 0.33% of ContraVir Pharmaceuticals' shares are currently sold short. Learn More on ContraVir Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.33% of ContraVir Pharmaceuticals' floating shares are currently sold short.

ContraVir Pharmaceuticals saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 52,400 shares, a drop of 67.6% from the previous total of 161,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

ContraVir Pharmaceuticals currently has issued a total of 800,000 shares. Some of ContraVir Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ContraVir Pharmaceuticals currently has a public float of 15,850,000 shares.

0.33% of ContraVir Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ContraVir Pharmaceuticals: Elevai Labs, Inc. (11.28%), GRI Bio, Inc. (7.73%), Bionomics Limited (0.08%), Clever Leaves Holdings Inc. (2.22%), ZyVersa Therapeutics, Inc. (0.91%), Altamira Therapeutics Ltd. (0.31%), Phio Pharmaceuticals Corp. (2.57%), Tharimmune, Inc. (1.57%), Psyence Biomedical Ltd. (6.50%), Entero Therapeutics, Inc. (6.40%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Electronics For Imaging, Inc. ($108.67 million), OHR Pharmaceutical Inc ($968,440.00), and Flex Pharma Inc ($414,047.20). View all of the most shorted stocks.

Short selling CTRV is an investing strategy that aims to generate trading profit from ContraVir Pharmaceuticals as its price is falling. CTRV shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ContraVir Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTRV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTRV, twice per month. The most recent reporting period available is June, 30 2019.